Delisting risk
Aptorum Group (APM)
Developing oncology, infectious disease, and diagnostic assets for unmet medical needs.
$8.26
At close−1.44 (−14.84%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
101.8K ADS (1 ADS = 8 ordinary shares) as of Sep 3, 2026 · holders as of their latest filing
Two share counts disagree (101.8K in the company's Sep 3, 2026 report, 634.7K elsewhere); stakes use the report.
This company has 2 share classes; every stake here is a share of the whole company.
Institutions13F
No 13F holders on record.
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Kira S. Sheinerman | 51.56% | 1.52M | 13D | Jul 24, 2026 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
